POPULAR

Medicinal cannabis: Patient access and clinical evidence

In the August 2017 edition of Australian Pharmacist (page 10), I provided background on the regulatory scheme for cultivation and manufacture of medicinal cannabis,...

Making a point: Pharmacist immunisation in 2018

Australia’s first pharmacist-administered vaccine trial began in 2014. Since then, pharmacist immunisation programs have begun in every state, and are now essential to public...

Collaborate for RA patient benefits

Achieving better outcomes for rheumatoid arthritis patients requires successful collaboration between specialists, GPs and pharmacists. A new NPS MedicineWise education program has highlighted the importance...

A cup of tea, a Bex and a good lie down

Immortalised in Australian slang, the analgesic phenacetin (used in Bex powder) is wrapped up in the development of the modern pharmaceutical industry and has...

Cost savings from pharmacist-led post-discharge care

US research has found pharmacist-led post-discharge care for high-risk patients resulted in fewer admissions and healthcare cost savings of more than $US500 per patient. In...

Clinical and consultant pharmacist Susanne Weress

Susanne Weress’s pharmacy career has taken her from Sydney to London, Singapore to Sri Lanka and Kenya to Kyrgyzstan. Bookending that incredible journey has...